Page 2 - Patrickw Smith News Today

UBS Group AG grew its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 65.4% in the 4th quarter, Holdings Channel reports. The fund owned 110,716 shares of the biotechnology company’s stock after buying an additional 43,779 shares during the period. UBS Group AG’s holdings in Axon Enterprise were worth $18,371,000 at […]

Jennison Associates LLC purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 2,094 shares of the biotechnology company’s stock, valued at approximately $347,000. Several other hedge funds and other institutional investors have also made changes […]

Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) has received a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price objective among brokerages […]

Abrdn plc increased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 3.4% during the 4th quarter, Holdings Channel reports. The firm owned 442,466 shares of the biotechnology company’s stock after buying an additional 14,401 shares during the period. abrdn plc’s holdings in Axon Enterprise were worth $73,418,000 at the end of the […]

Axon Enterprise (NASDAQ:AXON – Get Rating) had its target price hoisted by Robert W. Baird from $237.00 to $240.00 in a research report report published on Thursday morning, The Fly reports. Several other research firms have also commented on AXON. Craig Hallum lifted their price target on Axon Enterprise from $215.00 to $242.00 in a […]

Axon Enterprise (NASDAQ:AXON – Get Rating) had its price target boosted by Credit Suisse Group from $300.00 to $309.00 in a report released on Wednesday, The Fly reports. Other analysts have also issued research reports about the company. The Goldman Sachs Group began coverage on Axon Enterprise in a research note on Tuesday, March 7th. […]

Axon Enterprise (NASDAQ:AXON – Get Rating) had its price objective upped by Credit Suisse Group from $300.00 to $309.00 in a research note published on Wednesday, The Fly reports. AXON has been the subject of a number of other research reports. JMP Securities reiterated a market outperform rating and set a $235.00 price objective on […]

Axon Enterprise (NASDAQ:AXON – Get Rating) had its price objective lifted by Barclays from $222.00 to $256.00 in a report released on Wednesday, The Fly reports. Several other equities research analysts have also recently weighed in on AXON. JMP Securities reaffirmed a market outperform rating and set a $235.00 price objective on shares of Axon […]

Triasima Portfolio Management inc. bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 1,820 shares of the biotechnology company’s stock, valued at approximately $301,000. Several other hedge […]

JPMorgan Chase & Co. upgraded shares of Axon Enterprise (NASDAQ:AXON – Get Rating) from a neutral rating to an overweight rating in a report issued on Thursday morning, The Fly reports. The brokerage currently has $236.00 target price on the biotechnology company’s stock. AXON has been the subject of a number of other research reports. […]